|

Experimental: short-course radiotherapy and immunotherapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Hebei Medical University Fourth Hospital1

Indications

  • Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer1
  • Cancer1

Other1 trial

Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.